Clinical Pharmacokinetics of Alprazolam
- 1 June 1993
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 24 (6) , 453-471
- https://doi.org/10.2165/00003088-199324060-00003
Abstract
Alprazolam is a triazolobenzodiazepine that is extensively prescribed in the Western world for the treatment of anxiety and panic disorders. Its benzodiazepine receptor binding characteristics are...Keywords
This publication has 77 references indexed in Scilit:
- Clinical Pharmacokinetics of Anxiolytics and Hypnotics in the ElderlyClinical Pharmacokinetics, 1991
- Chronic Benzodiazepine Administration: From the Patient to the GeneThe Journal of Clinical Pharmacology, 1991
- Alprazolam in End-Stage Renal Disease: I. PharmacokineticsThe Journal of Clinical Pharmacology, 1991
- Pharmacokinetics and Pharmacodynamics of Alprazolam Following Single and Multiple Oral Doses of a Sustained-Release FormulationThe Journal of Clinical Pharmacology, 1989
- Lack of Effect of Influenza Vaccine on the Pharmacokinetics of Antipyrine, Alprazolam, Paracetamol (Acetaminophen) and LorazepamClinical Pharmacokinetics, 1989
- Metronidazole Impairs Clearance of Phenytoin but Not of Alprazolam or LorazepamThe Journal of Clinical Pharmacology, 1988
- Pharmacokinetics and Clinical Effects of Alprazolam Following Single and Multiple Oral Doses in Patients With Panic DisorderThe Journal of Clinical Pharmacology, 1986
- Alprazolam Pharmacokinetics in Alcoholic Liver DiseaseThe Journal of Clinical Pharmacology, 1984
- AlprazolamDrugs, 1984
- The Influence of Obesity on the Pharmacokinetics of Oral Alprazolam and TriazolamClinical Pharmacokinetics, 1984